(PSCH) Invesco S&P SmallCap Health - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E1495 • Health
PSCH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The Invesco S&P SmallCap Health Care ETF (PSCH) is an exchange-traded fund (ETF) that tracks the performance of small-capitalization U.S. companies in the health care sector. The fund invests at least 90% of its total assets in the securities of the S&P SmallCap 600 Health Care Index, which is compiled, maintained, and calculated by S&P Dow Jones Indices, LLC. This index is designed to measure the performance of small-cap U.S. healthcare companies, as defined by the Global Industry Classification Standard (GICS).
The ETF provides exposure to a specific segment of the healthcare industry, focusing on smaller companies that may offer growth potential. It is designed for investors seeking targeted exposure to the small-cap healthcare sector within the U.S. equity market.
Additional Sources for PSCH ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PSCH ETF Overview
Market Cap in USD | 168m |
Category | Health |
TER | 0.29% |
IPO / Inception | 2010-04-07 |
PSCH ETF Ratings
Growth 5y | 17.2% |
Fundamental | - |
Dividend | 28.5% |
Rel. Strength Industry | -9.26 |
Analysts | - |
Fair Price Momentum | 36.59 USD |
Fair Price DCF | - |
PSCH Dividends
Dividend Yield 12m | 0.28% |
Yield on Cost 5y | 0.40% |
Annual Growth 5y | 447.72% |
Payout Consistency | 22.8% |
PSCH Growth Ratios
Growth Correlation 3m | -16.9% |
Growth Correlation 12m | 65.5% |
Growth Correlation 5y | -28.3% |
CAGR 5y | 7.01% |
CAGR/Max DD 5y | 0.15 |
Sharpe Ratio 12m | 0.31 |
Alpha | -11.14 |
Beta | 0.95 |
Volatility | 28.28% |
Current Volume | 7.2k |
Average Volume 20d | 11.2k |
As of March 13, 2025, the stock is trading at USD 41.84 with a total of 7,247 shares traded.
Over the past week, the price has changed by -3.37%, over one month by -9.77%, over three months by -10.16% and over the past year by -1.88%.
Neither. Based on ValueRay Analyses, Invesco S&P SmallCap Health is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 17.16 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PSCH as of March 2025 is 36.59. This means that PSCH is currently overvalued and has a potential downside of -12.55%.
Invesco S&P SmallCap Health has no consensus analysts rating.
According to ValueRays Forecast Model, PSCH Invesco S&P SmallCap Health will be worth about 41.2 in March 2026. The stock is currently trading at 41.84. This means that the stock has a potential downside of -1.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 41.2 | -1.6% |